0001493152-18-003187.txt : 20180309 0001493152-18-003187.hdr.sgml : 20180309 20180309173018 ACCESSION NUMBER: 0001493152-18-003187 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180226 FILED AS OF DATE: 20180309 DATE AS OF CHANGE: 20180309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Richard Gregory CENTRAL INDEX KEY: 0001717470 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24249 FILM NUMBER: 18681269 MAIL ADDRESS: STREET 1: C/O INTERPACE DIAGNOSTICS GROUP, INC. STREET 2: 300 INTERPACE PARKWAY, BUILDING A CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Interpace Diagnostics Group, Inc. CENTRAL INDEX KEY: 0001054102 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 222919486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING C, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 412-224-6100 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING C, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: PDI INC DATE OF NAME CHANGE: 20021113 FORMER COMPANY: FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC DATE OF NAME CHANGE: 19980129 4 1 form4.xml X0306 4 2018-02-26 0 0001054102 Interpace Diagnostics Group, Inc. IDGX 0001717470 Richard Gregory C/O INTERPACE DIAGNOSTICS GROUP, INC. 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 0 1 0 0 Chief Commerical Officer Common Stock 2018-02-26 4 M 0 2000 A 3241 D Common Stock 2018-03-07 4 A 0 28000 A 31241 D Restricted Stock Units 2018-02-26 4 M 0 2000 0 D Common Stock 2000 2000 D Stock Option (right to buy) 1.01 2018-03-07 4 A 0 112000 0 A 2028-03-07 Common Stock 112000 112000 D Mr. Richard received 6,000 restricted stock units on February 26, 2016. 2,000 restricted stock units vested and 759 restricted stock units were withheld for taxes before Mr. Richard was required to report his holdings, 2,000 restricted stock units vested on February 26, 2018 and the remaining 2,000 restricted stock units will vest on February 26, 2019. Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer"). The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019. The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer. /s/ Gregory Richard 2018-03-09